Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 1]
A Phase 1 trial evaluating the combination of tipifarnib and etoposide in older adults with newly diagnosed acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome [Phase 1, Phase 2]
This update summarizes a Phase 1/2 clinical trial of a vaccine therapy with an immune adjuvant in patients with chronic myeloid leukemia, ac…
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia [Phase 1]
This entry reports the termination of a Phase 1 clinical trial investigating a vaccine therapy for acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2012-12-24Clinical Trial Update: Phase I Study in RAD 001 Patients With Relapse AML [Phase 1]
Phase I study of RAD 001 (ridaforolimus) in patients with relapsed acute myeloid leukemia has been completed.
-
CLINICAL_TRIALS trial_result · 2012-12-17Clinical Trial Update: Efficacy of 5-azacytidine Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) [Phase 2]
Phase 2 trial evaluating adding 5-azacytidine to standard frontline therapy in elderly patients with newly diagnosed AML has completed. The …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor [Phase 2]
Phase 2 study evaluating parathyroid hormone after sequential cord blood transplantation from an unrelated donor; the trial was terminated a…
-
CLINICAL_TRIALS trial_result · 2012-11-30Clinical Trial Update: Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluated combination chemotherapy with PSC-833 (valspodar) followed by interleukin-2 in patients with acute myel…
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
This clinical trial evaluated non-myeloablative allogeneic stem cell transplantation with matched unrelated donors across several hematologi…
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Natural Killer (NK) Cell Transplantation for AML [NA]
A completed clinical trial evaluating natural killer cell transplantation for acute myeloid leukemia has posted results in 2012.
-
CLINICAL_TRIALS trial_result · 2012-11-08Clinical Trial Update: Risk Adapted Treatment for Primary Acute Myeloid Leukemia (AML) [Phase 2]
A Phase 2 trial evaluating risk-adapted treatment for primary acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-01Clinical Trial Update: Risk-adapted Therapy for Adult Acute Myeloid Leukemia. [Phase 2]
A Phase 2 clinical trial of risk-adapted therapy for adult acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Biology and Treatment Strategy of AML in Its Subgroups: Multicenter Randomized Trial by the German Acute Myeloid Leukemia Cooperative Group (AMLCG) [Phase 3]
Phase 3 multicenter randomized trial by AMLCG on biology and treatment strategies for acute myeloid leukemia; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-19Clinical Trial Update: Bendamustine in Acute Leukemia and MDS [Phase 1, Phase 2]
Phase 1/2 trial of bendamustine in acute leukemia and myelodysplastic syndromes was terminated with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: A Study of Decitabine in Combination With Escalating Doses of Rapamycin in Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
This Phase 1 trial investigates decitabine in combination with escalating doses of rapamycin in patients with relapsed or refractory acute m…
-
CLINICAL_TRIALS trial_result · 2012-09-17Clinical Trial Update: Safety and Efficacy Study of Ara-c at 18 gm/m2 Versus 12 gm/m2 for 3 Cycles Each in AML Consolidation [Phase 3]
Phase 3 clinical trial comparing Ara-C at 18 g/m2 vs 12 g/m2 for 3 cycles as consolidation in acute myeloid leukemia; current status is unkn…
-
CLINICAL_TRIALS trial_result · 2012-08-31Clinical Trial Update: Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies [Phase 1]
Phase 1 dose-escalation study of CAL-101 in relapsed or refractory hematologic malignancies has completed, evaluating safety and preliminary…
-
CLINICAL_TRIALS trial_result · 2012-08-27Clinical Trial Update: S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML [Phase 3]
Phase 3 trial S0106 in de novo acute myeloid leukemia comparing cytarabine and daunorubicin with or without gemtuzumab ozogamicin, followed …
-
CLINICAL_TRIALS trial_result · 2012-08-27Clinical Trial Update: Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia [Phase 3]
This Phase 3 trial evaluating chemotherapy with or without gemtuzumab ozogamicin in older patients with acute myeloid leukemia has completed…
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation [Phase 2]
Phase 2 trial of CEP-701 (lestaurtinib) in patients with refractory acute myeloid leukemia with FLT-3 mutation has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-22Clinical Trial Update: CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse [Phase 2]
Pfizer's CMA-676 was studied in older patients with acute myeloid leukemia in first relapse in a Phase 2 trial. The study status is complete…
-
CLINICAL_TRIALS trial_result · 2012-08-22Clinical Trial Update: CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse [Phase 2]
Pfizer completed a Phase 2 trial of CMA-676 for treating patients with acute myeloid leukemia in first relapse.
-
CLINICAL_TRIALS trial_result · 2012-08-09Clinical Trial Update: Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB) [Phase 1, Phase 2]
Clinical trial update on a reduced-intensity preparative regimen followed by stem cell transplantation (FAB) in several hematologic malignan…
-
CLINICAL_TRIALS trial_result · 2012-08-08Clinical Trial Update: Combination of Nilotinib (AMN107) and RAD001 in Patients With Acute Myeloid Leukemia [Phase 1, Phase 2]
A Phase 1/2 trial evaluated the combination of nilotinib and RAD001 (everolimus) in patients with acute myeloid leukemia; the study has comp…
-
CLINICAL_TRIALS trial_result · 2012-08-07Clinical Trial Update: Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome [Phase 2]
Phase 2 clinical trial evaluating chemotherapy followed by bone marrow transplantation in patients with acute myeloid leukemia or myelodyspl…
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: Effectiveness of Protected Environment Rooms for AML and MDS
Clinical trial update on the effectiveness of protected environment rooms for Acute Myeloid Leukemia and Myelodysplastic Syndrome; the study…